Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS10038413HBVENSG00000000938.13protein_codingFGRNoNo2268P09769
TVIS30074496HIVENSG00000000938.13protein_codingFGRNoNo2268P09769
TVIS30074497HIVENSG00000000938.13protein_codingFGRNoNo2268P09769
TVIS30079787HIVENSG00000000938.13protein_codingFGRNoNo2268P09769
TVIS30022806HIVENSG00000000938.13protein_codingFGRNoNo2268P09769
TVIS30022807HIVENSG00000000938.13protein_codingFGRNoNo2268P09769
TCGA Plot Options
Drug Information
GeneFGR
DrugBank IDDB15035
Drug NameZanubrutinib
Target IDBE0005539
UniProt IDP09769
Regulation Typeinhibitor
PubMed IDs31381333
CitationsGuo Y, Liu Y, Hu N, Yu D, Zhou C, Shi G, Zhang B, Wei M, Liu J, Luo L, Tang Z, Song H, Guo Y, Liu X, Su D, Zhang S, Song X, Zhou X, Hong Y, Chen S, Cheng Z, Young S, Wei Q, Wang H, Wang Q, Lv L, Wang F, Xu H, Sun H, Xing H, Li N, Zhang W, Wang Z, Liu G, Sun Z, Zhou D, Li W, Liu L, Wang L, Wang Z: Discovery of Zanubrutinib (BGB-3111), a Novel, Potent, and Selective Covalent Inhibitor of Bruton's Tyrosine Kinase. J Med Chem. 2019 Sep 12;62(17):7923-7940. doi: 10.1021/acs.jmedchem.9b00687. Epub 2019 Aug 19.
GroupsApproved; Investigational
Direct ClassificationDiphenylethers
SMILESNC(=O)C1=C2NCC[C@@H](C3CCN(CC3)C(=O)C=C)N2N=C1C1=CC=C(OC2=CC=CC=C2)C=C1
Pathways
PharmGKB
ChEMBLCHEMBL3936761